Milestone Pharmaceuticals - Crunchbase Company Profile & Funding

Q: Who invested in Milestone Pharmaceuticals?

Milestone Pharmaceuticals has 20 investors including RTW Investments And Amplitude Venture Capital.

Q: How much funding has Milestone Pharmaceuticals raised to date?

Milestone Pharmaceuticals has raised obfuscated.

Overview

Milestone Pharmaceuticals

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Milestone Pharmaceuticals

CB Rank

49175

Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.

Founded

obfuscation

Public

Post-IPO Equity

Montréal, Quebec, Canada

11-50

www.milestonepharma.com

Biotechnology

Health Care

Therapeutics

Funding Rounds

Post-IPO Equity

OBF

obfuscation

Post-IPO Equity

OBF

obfuscation

Post-IPO Debt

OBF

obfuscation

Key People

Joseph G. Oliveto: President & Chief Executive Officer
Past Role: Roche, Director
Amit Hasija: Chief Financial Officer and Executive Vice President of Corporate Development

Details

Legal Name

Milestone Pharmaceuticals, Inc.

Operating Status

Active

Stock Symbol

NASDAQ:MIST

Company Type

For Profit

Founders

Philippe Douville

About the Company

Milestone Pharmaceuticals is a drug development company developing novel small molecule therapeutics based on clinically validated mechanisms for cardiovascular diseases. Milestone's lead product is a novel and potent short-acting calcium channel antagonist for the systemic treatment of transient cardiovascular conditions such as atrial

arrhythmias and angina.

Phone Number

(514) 336-0444

Contact Email

info@milestonepharma.com

Predictions & Insights

Growth Insight

See this Growth Insight

Milestone Pharmaceuticals is

Lorem

to be growing

Top Contributing Factors

Financial Growth

Products & Services

Etripamil

An investigational small molecule therapeutic designed for self-administration to treat episodic cardiovascular conditions such as paroxysmal supraventricular tachycardia (PSVT) and atrial fibrillation with rapid ventricular rate (AFib-RVR).

CARDAMYST nasal spray

A nasal spray treatment for paroxysmal supraventricular tachycardia (PSVT).

Research & Development

Milestone Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Milestone Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Milestone Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Milestone Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Milestone Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Milestone Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Milestone Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Milestone Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Milestone Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Milestone Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Milestone Pharmaceuticals	—	obfuscated obfuscation	—	Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
RTW Investments	Yes	Post-IPO Debt - Milestone Pharmaceuticals	Roderick Wong
RTW Investments	Yes	Post-IPO Debt - Milestone Pharmaceuticals	Roderick Wong
RTW Investments	Yes	Post-IPO Debt - Milestone Pharmaceuticals	Roderick Wong
RTW Investments	Yes	Post-IPO Debt - Milestone Pharmaceuticals	Roderick Wong
RTW Investments	Yes	Post-IPO Debt - Milestone Pharmaceuticals	Roderick Wong

Market Intelligence

People

View Profiles & Contacts

Headcount

11-50

Employee Profiles

Board Members and Advisors

Contacts

Employee Profiles

Joseph G. Oliveto President & Chief Executive Officer
Amit Hasija Chief Financial Officer and Executive Vice President of Corporate Development
Eric W. Linsley Director
David Sandoval General Counsel and Chief Compliance Officer